Brewer says use of drug such as wegovy could reduce desire to drink alcohol. Heineken warns bar and pubs that boom in popularity of weightloss drugs could lead to fall in sales of beer.
10 million people turned to medication in the us last year, according to research. The brewer said the presentation was shared as part of its engagement with UK businesses.
Diageo told investors that any impact from the use of GLP-1 drugs should be manageable. But a survey by research companies has pointed to reduced drinking by users. There were almost £14bn in beer sales in the year to February.
This summary was written with AI assistance from the original article and may leave out important context. The original reporting belongs to The Guardian · Health. Check the original, and official sources, before acting on any detail.